Cargando…

What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation

BACKGROUND: Although PCNL has been used for a long time to treat nephrolithiasis, there is still contradictory information concerning the use of the dilation method. In this study, we aimed to compare conventional sequential Amplatz dilatation (SAD) using ten dilators and a method using three dilato...

Descripción completa

Detalles Bibliográficos
Autores principales: Memik, Omur, Voyvoda, Bekir, Ustuner, Murat, Karsli, Onur, Halat, Ahmed Omer, Ozcan, Levent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687924/
https://www.ncbi.nlm.nih.gov/pubmed/38031043
http://dx.doi.org/10.1186/s12894-023-01368-6
_version_ 1785152073762865152
author Memik, Omur
Voyvoda, Bekir
Ustuner, Murat
Karsli, Onur
Halat, Ahmed Omer
Ozcan, Levent
author_facet Memik, Omur
Voyvoda, Bekir
Ustuner, Murat
Karsli, Onur
Halat, Ahmed Omer
Ozcan, Levent
author_sort Memik, Omur
collection PubMed
description BACKGROUND: Although PCNL has been used for a long time to treat nephrolithiasis, there is still contradictory information concerning the use of the dilation method. In this study, we aimed to compare conventional sequential Amplatz dilatation (SAD) using ten dilators and a method using three dilators (12, 20, and 30 Fr), which we named “three-shot dilatation” (3SD), in terms of fluoroscopy time (FT), operation time, bleeding and stone-free rates. METHODS: The study included patients who underwent PCNL with the SAD and 3SD methods. A different surgeon with extensive endourology experience applied each technique. One of the surgeons operated on the patients using the SAD method with ten dilators, and the other surgeon performed the operations using the 3SD method involving three Amplatz dilators (12, 20, and 30 Fr). RESULTS: A total of 283 patients, 138 in the 3SD group and 145 in the SAD group, were included in the study. The mean age of the patients was 47.32 ± 13.71 years. There was no statistically significant difference between the two groups regarding preoperative characteristics (p > 0.05). The FTs of access 2, total access, and total operation were significantly shorter in the 3SD group (p = 0.0001). The decrease in hemoglobin was statistically significant in the 3SD group compared to the SAD group (p = 0.022), while the blood transfusion requirements of the groups were similar (p = 0.176). There was no statistically significant difference between the two groups regarding stone-free rates (p = 0.973). In four patients in the SAD group, re-access was necessary due to the loss of passage due to the guide wire slipping out of its place. CONCLUSION: Intraoperative FT can be shortened using the described 3SD method without compromising surgical safety. However, this method can be used as an intermediate step in the transition to one-shot dilation by surgeons experienced in performing SAD.
format Online
Article
Text
id pubmed-10687924
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106879242023-11-30 What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation Memik, Omur Voyvoda, Bekir Ustuner, Murat Karsli, Onur Halat, Ahmed Omer Ozcan, Levent BMC Urol Research BACKGROUND: Although PCNL has been used for a long time to treat nephrolithiasis, there is still contradictory information concerning the use of the dilation method. In this study, we aimed to compare conventional sequential Amplatz dilatation (SAD) using ten dilators and a method using three dilators (12, 20, and 30 Fr), which we named “three-shot dilatation” (3SD), in terms of fluoroscopy time (FT), operation time, bleeding and stone-free rates. METHODS: The study included patients who underwent PCNL with the SAD and 3SD methods. A different surgeon with extensive endourology experience applied each technique. One of the surgeons operated on the patients using the SAD method with ten dilators, and the other surgeon performed the operations using the 3SD method involving three Amplatz dilators (12, 20, and 30 Fr). RESULTS: A total of 283 patients, 138 in the 3SD group and 145 in the SAD group, were included in the study. The mean age of the patients was 47.32 ± 13.71 years. There was no statistically significant difference between the two groups regarding preoperative characteristics (p > 0.05). The FTs of access 2, total access, and total operation were significantly shorter in the 3SD group (p = 0.0001). The decrease in hemoglobin was statistically significant in the 3SD group compared to the SAD group (p = 0.022), while the blood transfusion requirements of the groups were similar (p = 0.176). There was no statistically significant difference between the two groups regarding stone-free rates (p = 0.973). In four patients in the SAD group, re-access was necessary due to the loss of passage due to the guide wire slipping out of its place. CONCLUSION: Intraoperative FT can be shortened using the described 3SD method without compromising surgical safety. However, this method can be used as an intermediate step in the transition to one-shot dilation by surgeons experienced in performing SAD. BioMed Central 2023-11-29 /pmc/articles/PMC10687924/ /pubmed/38031043 http://dx.doi.org/10.1186/s12894-023-01368-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Memik, Omur
Voyvoda, Bekir
Ustuner, Murat
Karsli, Onur
Halat, Ahmed Omer
Ozcan, Levent
What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation
title What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation
title_full What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation
title_fullStr What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation
title_full_unstemmed What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation
title_short What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation
title_sort what is the safe and effective dilator number during access in pcnl? three-shot dilation versus classical sequential amplatz dilation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687924/
https://www.ncbi.nlm.nih.gov/pubmed/38031043
http://dx.doi.org/10.1186/s12894-023-01368-6
work_keys_str_mv AT memikomur whatisthesafeandeffectivedilatornumberduringaccessinpcnlthreeshotdilationversusclassicalsequentialamplatzdilation
AT voyvodabekir whatisthesafeandeffectivedilatornumberduringaccessinpcnlthreeshotdilationversusclassicalsequentialamplatzdilation
AT ustunermurat whatisthesafeandeffectivedilatornumberduringaccessinpcnlthreeshotdilationversusclassicalsequentialamplatzdilation
AT karslionur whatisthesafeandeffectivedilatornumberduringaccessinpcnlthreeshotdilationversusclassicalsequentialamplatzdilation
AT halatahmedomer whatisthesafeandeffectivedilatornumberduringaccessinpcnlthreeshotdilationversusclassicalsequentialamplatzdilation
AT ozcanlevent whatisthesafeandeffectivedilatornumberduringaccessinpcnlthreeshotdilationversusclassicalsequentialamplatzdilation